Todd Chappell Appointed CEO of Rasio Therapeutics

Published on :

Todd Chappell  Appointed CEO of Rasio Therapeutics Chappell is a 20-year veteran of the biopharma industry with experience running multiple drug development programs from the discovery stage through to clinical trials November 14, 2019, Baltimore, MD – Rasio Therapeutics, Inc., a biopharmaceutical company that develops novel medicines using cutting-edge computer-aided drug design technology, today announced the appointment of Todd Chappell, a veteran medtech and [….]